Genetically predicted telomere length is not associated with pancreatic cancer risk

Samuel Antwi, William R. Bamlet, Brendan T. Broderick, Kari G. Chaffee, Ann L Oberg, Aminah Jatoi, Lisa Allyn Boardman, Gloria M Petersen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Epidemiologic associations of leukocyte telomere length (LTL) and pancreatic ductal adenocarcinoma(PDAC) have been inconsistent owing, in part, to variation in telomere length (TL) assessment across studies. To overcome this limitation and address concerns of potential reverse causation, we used carriage of telomere-related alleles to genetically predict TL and examined its association with PDAC. Methods: A case-control study of 1,500 PDAC cases and 1,500 controls, frequency-matched on age and sex was performed. Eight of nine polymorphisms previously associated with variation in LTL were analyzed. Genetic risk scores (GRS) consisting of the TLrelated polymorphisms were computed as the number of long TL alleles carried by an individual scaled to published kilobase pairs of TL associated with each allele. Participants were further categorized on the basis of the number of short TL alleles they carry across all eight SNPs. Associations were examined in additive and dominant models using logistic regression to calculate ORs and 95% confidence intervals (CI). Results: In age-and sex-adjusted models, one short TL allele (rs10936599, T) was associated with reduced risk, whereas another short TL allele (rs2736100, A) was associated with increased risk, with per-allele ORs of 0.89 (95% CI, 0.79-0.99) and 1.13 (95% CI, 1.01-1.24), respectively. No association was observed with GRS or short TL allele counts, and no associations were observed in the dominant models. Conclusions: Findings suggest that genetically predicted short TL is not associated with PDAC risk. Impact: Common genetic determinants of short TL do not appear to influence PDAC risk.

Original languageEnglish (US)
Pages (from-to)971-974
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume26
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

Telomere
Pancreatic Neoplasms
Alleles
Adenocarcinoma
Confidence Intervals
Leukocytes
Causality
Single Nucleotide Polymorphism
Case-Control Studies
Logistic Models

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Genetically predicted telomere length is not associated with pancreatic cancer risk. / Antwi, Samuel; Bamlet, William R.; Broderick, Brendan T.; Chaffee, Kari G.; Oberg, Ann L; Jatoi, Aminah; Boardman, Lisa Allyn; Petersen, Gloria M.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 26, No. 6, 01.06.2017, p. 971-974.

Research output: Contribution to journalArticle

@article{a2438150c72f45fd9daeba0bdc7f5cd0,
title = "Genetically predicted telomere length is not associated with pancreatic cancer risk",
abstract = "Background: Epidemiologic associations of leukocyte telomere length (LTL) and pancreatic ductal adenocarcinoma(PDAC) have been inconsistent owing, in part, to variation in telomere length (TL) assessment across studies. To overcome this limitation and address concerns of potential reverse causation, we used carriage of telomere-related alleles to genetically predict TL and examined its association with PDAC. Methods: A case-control study of 1,500 PDAC cases and 1,500 controls, frequency-matched on age and sex was performed. Eight of nine polymorphisms previously associated with variation in LTL were analyzed. Genetic risk scores (GRS) consisting of the TLrelated polymorphisms were computed as the number of long TL alleles carried by an individual scaled to published kilobase pairs of TL associated with each allele. Participants were further categorized on the basis of the number of short TL alleles they carry across all eight SNPs. Associations were examined in additive and dominant models using logistic regression to calculate ORs and 95{\%} confidence intervals (CI). Results: In age-and sex-adjusted models, one short TL allele (rs10936599, T) was associated with reduced risk, whereas another short TL allele (rs2736100, A) was associated with increased risk, with per-allele ORs of 0.89 (95{\%} CI, 0.79-0.99) and 1.13 (95{\%} CI, 1.01-1.24), respectively. No association was observed with GRS or short TL allele counts, and no associations were observed in the dominant models. Conclusions: Findings suggest that genetically predicted short TL is not associated with PDAC risk. Impact: Common genetic determinants of short TL do not appear to influence PDAC risk.",
author = "Samuel Antwi and Bamlet, {William R.} and Broderick, {Brendan T.} and Chaffee, {Kari G.} and Oberg, {Ann L} and Aminah Jatoi and Boardman, {Lisa Allyn} and Petersen, {Gloria M}",
year = "2017",
month = "6",
day = "1",
doi = "10.1158/1055-9965.EPI-17-0100",
language = "English (US)",
volume = "26",
pages = "971--974",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Genetically predicted telomere length is not associated with pancreatic cancer risk

AU - Antwi, Samuel

AU - Bamlet, William R.

AU - Broderick, Brendan T.

AU - Chaffee, Kari G.

AU - Oberg, Ann L

AU - Jatoi, Aminah

AU - Boardman, Lisa Allyn

AU - Petersen, Gloria M

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background: Epidemiologic associations of leukocyte telomere length (LTL) and pancreatic ductal adenocarcinoma(PDAC) have been inconsistent owing, in part, to variation in telomere length (TL) assessment across studies. To overcome this limitation and address concerns of potential reverse causation, we used carriage of telomere-related alleles to genetically predict TL and examined its association with PDAC. Methods: A case-control study of 1,500 PDAC cases and 1,500 controls, frequency-matched on age and sex was performed. Eight of nine polymorphisms previously associated with variation in LTL were analyzed. Genetic risk scores (GRS) consisting of the TLrelated polymorphisms were computed as the number of long TL alleles carried by an individual scaled to published kilobase pairs of TL associated with each allele. Participants were further categorized on the basis of the number of short TL alleles they carry across all eight SNPs. Associations were examined in additive and dominant models using logistic regression to calculate ORs and 95% confidence intervals (CI). Results: In age-and sex-adjusted models, one short TL allele (rs10936599, T) was associated with reduced risk, whereas another short TL allele (rs2736100, A) was associated with increased risk, with per-allele ORs of 0.89 (95% CI, 0.79-0.99) and 1.13 (95% CI, 1.01-1.24), respectively. No association was observed with GRS or short TL allele counts, and no associations were observed in the dominant models. Conclusions: Findings suggest that genetically predicted short TL is not associated with PDAC risk. Impact: Common genetic determinants of short TL do not appear to influence PDAC risk.

AB - Background: Epidemiologic associations of leukocyte telomere length (LTL) and pancreatic ductal adenocarcinoma(PDAC) have been inconsistent owing, in part, to variation in telomere length (TL) assessment across studies. To overcome this limitation and address concerns of potential reverse causation, we used carriage of telomere-related alleles to genetically predict TL and examined its association with PDAC. Methods: A case-control study of 1,500 PDAC cases and 1,500 controls, frequency-matched on age and sex was performed. Eight of nine polymorphisms previously associated with variation in LTL were analyzed. Genetic risk scores (GRS) consisting of the TLrelated polymorphisms were computed as the number of long TL alleles carried by an individual scaled to published kilobase pairs of TL associated with each allele. Participants were further categorized on the basis of the number of short TL alleles they carry across all eight SNPs. Associations were examined in additive and dominant models using logistic regression to calculate ORs and 95% confidence intervals (CI). Results: In age-and sex-adjusted models, one short TL allele (rs10936599, T) was associated with reduced risk, whereas another short TL allele (rs2736100, A) was associated with increased risk, with per-allele ORs of 0.89 (95% CI, 0.79-0.99) and 1.13 (95% CI, 1.01-1.24), respectively. No association was observed with GRS or short TL allele counts, and no associations were observed in the dominant models. Conclusions: Findings suggest that genetically predicted short TL is not associated with PDAC risk. Impact: Common genetic determinants of short TL do not appear to influence PDAC risk.

UR - http://www.scopus.com/inward/record.url?scp=85020163158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020163158&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-17-0100

DO - 10.1158/1055-9965.EPI-17-0100

M3 - Article

C2 - 28264873

AN - SCOPUS:85020163158

VL - 26

SP - 971

EP - 974

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 6

ER -